ds15-15d_merck.htm
 
OMB APPROVAL
                                                                         UNITED STATES
                                                                        SECURITIES AND EXCHANGE COMMISSION
                                                                       Washington, D.C.  20549
OMB Number:      3235-0167
Expires:   November 30, 2010
Estimated average burden
hours per response . . . . .. 1.50

 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
                                                                                                                                      Commission File Number:                 333-160134
 

 
Merck Sharp & Dohme Corp. (f/k/a Merck & Co., Inc.)
(Exact name of registrant as specified in its charter)
 

 
One Merck Drive, P.O. Box 100, Whitehouse Station, NJ 08889-0100; (908) 423-1000
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
 
 
1.875% Notes due June 30, 2011
4.0% Notes due June 30, 2015
5.0% Notes due June 30, 2019
5.85% Notes due June 30, 2039
 (Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
 
    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1)
o
Rule 12g-4(a)(2)
o
Rule 12h-3(b)(1)(i)
o
Rule 12h-3(b)(1)(ii)
o
Rule 15d-6
ý
 
    Approximate number of holders of record as of the certification or notice date:
 
1.875% Notes due June 30, 2011          72
4.0% Notes due June 30, 2015              74
5.0% Notes due June 30, 2019              75
5.85% Notes due June 30, 2039            42
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, Merck Sharp & Dohme Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
.
  Merck Sharp & Dohme Corp.  
       
DATE:  January 12, 2010
By:
/s/ Debra A. Bollwage  
    Name:   Debra A. Bollwage  
    Title:     Assistant Secretary  
 
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.